Literature DB >> 28740958

The outcomes of intestinal resection during debulking surgery for ovarian cancer.

Serdar Gökay Terzioğlu1, Murat Özgür Kılıç1, Nilüfer Çetinkaya2, Eralp Baser2, Tayfun Güngör2, Cevdet Adıgüzel3.   

Abstract

OBJECTIVE: To evaluate the clinical and surgical outcomes of intestinal resection during primary debulking surgery for ovarian cancer.
MATERIAL AND METHODS: This retrospective study was conducted at Zekai Tahir Burak Women's Health Training and Research Hospital between 2009 and 2013. The patients who underwent intestinal resection during debulking surgery for stage 3 ovarian cancer were included in the analysis. Data regarding patient age, body mass index, tumor histology, disease stage, the site of intestinal resection, all postoperative complications, duration of intensive care unit admission and hospital stay were collected and analyzed.
RESULTS: A total of 22 patients with a mean age of 53.4 years were included in the study. Optimal cytoreduction was achieved in 14 (63%) patients. Transverse colectomy was the most common type of intestinal resection (63%). The most common postoperative complication was transfusion of blood products (63%). No postoperative mortality was observed.
CONCLUSION: Intestinal resection is a crucial part of debulking surgery for advanced ovarian cancer, with acceptable complication rates. Despite the limited number of patients, the results obtained from the present study are comparable with previous reports.

Entities:  

Keywords:  Cytoreductive surgery; debulking surgery; intestinal resection; morbidity; ovarian cancer

Year:  2017        PMID: 28740958      PMCID: PMC5508250          DOI: 10.5152/UCD.2016.3515

Source DB:  PubMed          Journal:  Turk J Surg        ISSN: 2564-6850


  27 in total

1.  Surgical versus chemical upfront debulking in advanced ovarian cancer.

Authors:  S. Pecorelli; G. Favalli
Journal:  Int J Gynecol Cancer       Date:  2000-01       Impact factor: 3.437

2.  The role of bowel surgery with cytoreduction for epithelial ovarian cancer.

Authors:  H-B Cai; Y-F Zhou; H-Z Chen; H-Y Hou
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-09-21       Impact factor: 4.126

3.  Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.

Authors:  Robert E Bristow; Michele Peiretti; Vanna Zanagnolo; Ritu Salani; Robert L Giuntoli; Angelo Maggioni
Journal:  Gynecol Oncol       Date:  2008-04-08       Impact factor: 5.482

Review 4.  2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.

Authors:  Gavin C E Stuart; Henry Kitchener; Monica Bacon; Andreas duBois; Michael Friedlander; Jonathan Ledermann; Christian Marth; Tate Thigpen; Edward Trimble
Journal:  Int J Gynecol Cancer       Date:  2011-05       Impact factor: 3.437

5.  Neoadjuvant chemotherapy in advanced ovarian cancer: On what do we agree and disagree?

Authors:  Ignace Vergote; Andreas du Bois; Frederic Amant; Florian Heitz; Karin Leunen; Philipp Harter
Journal:  Gynecol Oncol       Date:  2012-09-21       Impact factor: 5.482

Review 6.  Intestinal surgery in advanced ovarian cancer.

Authors:  Osamu Takahashi; Toshinobu Tanaka
Journal:  Curr Opin Obstet Gynecol       Date:  2007-02       Impact factor: 1.927

Review 7.  Cytoreductive surgery for ovarian cancer.

Authors:  T C Randall; S C Rubin
Journal:  Surg Clin North Am       Date:  2001-08       Impact factor: 2.741

8.  Assessment of risk factors for 30-day hospital readmission after surgical cytoreduction in epithelial ovarian carcinoma.

Authors:  Janelle M Fauci; Kellie E Schneider; Peter J Frederick; Gregory Wilding; Joe Consiglio; Amelia L Sutton; Larry C Kilgore; Mack N Barnes
Journal:  Int J Gynecol Cancer       Date:  2011-07       Impact factor: 3.437

9.  Patient, treatment and discharge factors associated with hospital readmission within 30 days after surgical cytoreduction for epithelial ovarian carcinoma.

Authors:  Rachel M Clark; Whitfield B Growdon; Andrew Wiechert; David Boruta; Marcela Del Carmen; Anne Kathryn Goodman; Leslie Bradford; Alejandro Rauh-Hain; John O Schorge
Journal:  Gynecol Oncol       Date:  2013-06-05       Impact factor: 5.482

10.  Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).

Authors:  Andreas du Bois; Alexander Reuss; Eric Pujade-Lauraine; Philipp Harter; Isabelle Ray-Coquard; Jacobus Pfisterer
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

View more
  1 in total

1.  Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis.

Authors:  Beatriz Navarro Santana; Esmeralda Garcia Torralba; Jose Verdu Soriano; Maria Laseca; Alicia Martin Martinez
Journal:  J Gynecol Oncol       Date:  2022-03       Impact factor: 4.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.